Related Experiment Video
Updated: May 12, 2026

08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine affects pancreatic cell proteomics across species
1Merck Millipore, Schaffhausen, Switzerland. christian.dittrich@merckgroup.com
Proteomics
|April 23, 2013
Summary
This study reveals nicotine's effects on pancreatic stellate cells across species. Understanding these proteomic changes is crucial for pancreatic disease research and developing targeted therapies.
Area of Science:
- Proteomics
- Cellular Biology
- Toxicology
Background:
- The genome is static, but the proteome dynamically responds to stimuli, offering insights into drug effects.
- Nicotine is a known risk factor for various diseases, yet its mechanism in pancreatic disease is unclear.
- Species-specific differences in cellular responses to toxins are critical for translational research.
Purpose of the Study:
- To investigate the impact of nicotine on pancreatic stellate cells.
- To identify species-specific proteomic alterations induced by nicotine exposure.
- To advance the understanding of nicotine's role in pancreatic disease pathogenesis.
Main Methods:
- Proteomic analysis of pancreatic stellate cells.
- Exposure of cells to nicotine across three different species.
- Quantitative measurement of protein alterations.
Main Results:
- Nicotine exposure induced significant proteomic changes in pancreatic stellate cells.
- Demonstrated distinct, species-specific responses to nicotine.
- Highlighted the variability in cellular mechanisms across species.
Conclusions:
- Proteomics is a valuable tool for dissecting drug effects and species differences.
- Nicotine's action on pancreatic stellate cells varies by species.
- Further research into these species-specific effects is essential for understanding pancreatic disease.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
